BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

May 08, 2017

|

NEW YORK (GenomeWeb) – Becton Dickinson today said it has commenced registered offerings of $2.25 billion of common stock and $2.25 billion of depositary shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

To read the full story....

Breaking News

JP Morgan Downgrades Illumina to Neutral on Grail Deal

Ortho Clinical Diagnostics Nabs $12.9M BARDA Award for SARS-CoV-2 Antigen, Antibody Tests

Arna Genomics Raises $3.5M In Series A Financing

Biocept Lung Cancer Liquid Biopsy Test Obtains Coverage From Blue Cross Affiliate Highmark

Illumina to Acquire Grail for $8B in Cash and Stock

Scanwell Health Receives $1.6M NIH Grant to Develop At-Home Test for Chronic Kidney Disease

What's Popular?

Illumina to Acquire Grail for $8B in Cash and Stock

FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

Cellex, Gauss Partner on At-Home, Point-of-Care Coronavirus Antigen Test

Sponsorships